Britney A. Stottlemyer

Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study

Britney A. Stottlemyer, Michael C. McDermott, Mackenzie R. Minogue et al. · Therapeutic Advances in Drug Safety · 2023 · 31 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacology +17

A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database

Niti M. Patel, Britney A. Stottlemyer, Matthew P. Gray et al. · Cardiovascular Drugs and Therapy · 2021 · 30 citations

Pharmacy, Cardiology, Pharmacology +16

Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey

Amy J. Grizzle, John R. Horn, Carol Collins et al. · Journal of Medical Internet Research · 2018 · 23 citations · Full text

Pharmacy, Pharmacology, Clinical Decision Support +16

Expert Consensus on the Nephrotoxic Potential of 195 Medications in the Non-intensive Care Setting: A Modified Delphi Method

Britney A. Stottlemyer, Kaleab Z. Abebe, Paul M. Palevsky et al. · Drug Safety · 2023 · 17 citations · Full text

Medicine, Nephrology, Pharmacology +13

The Acute Kidney Intervention and Pharmacotherapy (AKIP) List: Standardized List of Medications That Are Renally Eliminated and Nephrotoxic in the Acutely Ill

Erin F. Barreto, Alexis M. Gaggani, Brandy N. Hernandez et al. · Annals of Pharmacotherapy · 2024 · 12 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17